A receptor-antibody hybrid hampering MET-driven metastatic spread.
Chiara ModicaCristina BasilicoCristina ChiriacoNicla BorrelliPaolo M ComoglioElisa VignaPublished in: Journal of experimental & clinical cancer research : CR (2021)
These results provide a strategy to treat metastatic dissemination driven by the HGF/MET axis.